Related Experiment Videos
Distinct functional domains on the recombinant human immune interferon molecule
Cancer Research
|December 1, 1986
Summary
Monoclonal antibodies reveal distinct functional domains of recombinant human immune interferon (rIFN-gamma). These antibodies block antiviral and antiproliferative effects but not binding or reduction of a melanoma antigen, suggesting separate molecular regions govern these activities.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Interferon-gamma (IFN-gamma) is a crucial cytokine with diverse biological activities.
- Understanding the molecular basis of IFN-gamma's functions is key to its therapeutic applications, particularly in cancer.
- Melanoma cells express specific antigens and respond to IFN-gamma, making them a relevant model system.
Purpose of the Study:
- To investigate the relationship between the molecular structure of recombinant human immune interferon (rIFN-gamma) and its biological activities.
- To determine which functional domains of rIFN-gamma are responsible for specific cellular responses in human melanoma cells.
- To differentiate the mechanisms underlying IFN-gamma's effects on antigen expression, proliferation, and viral response.
Main Methods:
- Utilized two distinct monoclonal antibodies targeting specific epitopes of rIFN-gamma.
- Assessed the impact of these antibodies on rIFN-gamma's binding to cultured human melanoma cells.
- Evaluated the effects of antibody-bound rIFN-gamma on cell surface human lymphocyte antigen expression (Class I and II), antiproliferative activity, antiviral action, and modulation of a high molecular weight-melanoma associated antigen.
Main Results:
- Both monoclonal antibodies effectively inhibited the rIFN-gamma-induced increase in Class I and II human lymphocyte antigen expression.
- Antiproliferative and antiviral activities of rIFN-gamma were also significantly inhibited by both antibodies.
- Neither antibody interfered with the binding of rIFN-gamma to melanoma cells or its capacity to decrease the expression of a high molecular weight-melanoma associated antigen.
Conclusions:
- The functional domains of rIFN-gamma responsible for antiviral and antiproliferative effects, as well as enhancing human lymphocyte antigen expression, are distinct.
- These domains appear separate from the region(s) involved in binding to cell receptors and reducing the expression of the high molecular weight-melanoma associated antigen.
- This suggests a complex molecular organization of rIFN-gamma, with specific regions mediating different biological outcomes.